Your browser doesn't support javascript.
loading
Anticipatory regulation for pandemic responses: are we there yet?
Oyola-Lozada, Maria Giuliana; Pregelj, Lisette; Jenkins, Anna; Siegel, Evan; Munro, Trent; Hine, Damian.
Afiliación
  • Oyola-Lozada MG; The University of Queensland School of Business, The University of Queensland, St Lucia, Queensland 4072, Australia; ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • Pregelj L; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, Queensland 4072, Australia. Electronic address: lisette.pregelj@uq.edu.au.
  • Jenkins A; The University of Queensland School of Business, The University of Queensland, St Lucia, Queensland 4072, Australia; ARC Training Centre for Innovation in Biomedical Imaging Technology, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • Siegel E; GroundZero Pharmaceuticals, Irvine, CA, USA.
  • Munro T; Australian Institute of Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland 4072, Australia.
  • Hine D; Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, St Lucia, Queensland 4072, Australia.
Trends Biotechnol ; 42(9): 1067-1071, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38538499
ABSTRACT
Can drug and vaccine regulatory agencies leverage their experience during the coronavirus disease 2019 (COVID-19) pandemic to advance from reactive regulation to adaptive regulation and beyond to anticipatory regulation to prevent or curb future pandemics?
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Trends Biotechnol Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Trends Biotechnol Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido